The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates
Open accessAbstract
The neonatal Fc receptor (FcRn) plays an important role in regulating the serum half-lives of IgG antibodies. A correlation has been established between the pH-dependent binding affinity of IgG antibodies to FcRn and their serum half-lives in mice. In this study, molecular modeling was used to identify Fc positions near the FcRn binding site in a human IgG antibody that, when mutated, might alter the binding affinity of IgG to FcRn. Following mutagenesis, several IgG2 mutants with increased binding affinity to human FcRn at pH 6.0 were identified at Fc positions 250 and 428. These mutants do not bind to human FcRn at pH 7.5. A pharmacokinetics study of two mutant IgG2 antibodies with increased FcRn binding affinity indicated that they had serum half-lives in rhesus monkeys approximately 2-fold longer than the wild-type antibody.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
Morrison, S. L., Johnson, M. J., Herzenberg, L. A., & Oi, V. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6851 · Cited by 1,039
An Fc receptor structurally related to MHC class I antigens
Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729
PCR Technology: Principles and Applications for DNA Amplification
Kellis, M. (1989) · Medical Entomology and Zoology · Cited by 688
Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Immunotherapy: past, present and future
Waldmann, T. A. (2003) · Nature Medicine · doi:10.1038/nm0303-269 · Cited by 628
Accurate modeling of protein conformation by automatic segment matching
Levitt, M. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90964-l · Cited by 558
Tao, M. H., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 530
PCR Technology: Principles and Applications for DNA Amplification
Lynch, J. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.8.536 · Cited by 505
Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn
Ghetie, V., & Ward, E. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.739 · Cited by 474
Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice
Ghetie, V., Hubbard, J. G., Kim, J., Tsen, M., Lee, Y., & Ward, E. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260327 · Cited by 469
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Burmeister, W. P., Huber, A. H., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 431
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Martin, W. L., West, A. P., Gan, L., & Bjorkman, P. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00230-1 · Cited by 391
Crystal structure of the complex of rat neonatal Fc receptor with Fc
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 381
Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences
Acqua, W. F. D., Woods, R. M., Ward, E. S., Palaszynski, S. R., Patel, N. K., Brewah, Y. A., Wu, H., Kiener, P. A., & Langermann, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5171 · Cited by 368
Molecular dynamics of native protein
Levitt, M. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80304-0 · Cited by 356
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins
Caras, I. W., Davitz, M. A., Rhee, L., Weddell, G., Martin, D. W., & Nussenzweig, V. (1987) · Nature · doi:10.1038/325545a0 · Cited by 351
Increased clearance of IgG in mice that lack β2‐microglobulin: possible protective role of FcRn
ISRAEL, E. J., WILSKER, D. F., HAYES, K. C., SCHOENFELD, D., & SIMISTER, N. E. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-775.x · Cited by 333
Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J. (1995) · Biochemistry · doi:10.1021/bi00045a005 · Cited by 317
Engineered Antibodies with Increased Activity to Recruit Complement
Idusogie, E. E., Wong, P. Y., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Ultsch, M., & Mulkerrin, M. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2571 · Cited by 291
Higuchi, R. (1989) · PCR Technology · doi:10.1007/978-1-349-20235-5_6 · Cited by 291
Simmons, L. C., Reilly, D., Klimowski, L., Shantha Raju, T., Meng, G., Sims, P., Hong, K., Shields, R. L., Damico, L. A., Rancatore, P., et al. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00036-4 · Cited by 282
West, A. P., & Bjorkman, P. J. (2000) · Biochemistry · doi:10.1021/bi000749m · Cited by 257
Increasing the serum persistence of an IgG fragment by random mutagenesis
Ghetie, V., Popov, S., Borvak, J., Radu, C., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 241
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn
Kim, J.-K., Firan, M., Radu, C. G., Kim, C.-H., Ghetie, V., & Ward, E. S. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2819::aid-immu2819>3.0.co;2-6 · Cited by 222
Natural and designer binding sites made by phage display technology
Hoogenboom, H. R., & Chames, P. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01667-4 · Cited by 213
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1
Medesan, C., Matesoi, D., Radu, C., Ghetie, V, & Ward, E. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2211 · Cited by 175
Chimeric and humanized antibodies with specificity for the CD33 antigen
Co, M. S., Avdalovic, N. M., Caron, P. C., Avdalovic, M. V., Scheinberg, D. A., & Queen, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1149 · Cited by 147
Kim, J., Tsen, M. F., Ghetie, V. F., & Ward, E. S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240308 · Cited by 118
Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells
Cole, M. S., Anasetti, C., & Tso, J. Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3613 · Cited by 73
Self-citationCharacterization of human monoclonal antibodies directed against hepatitis B surface antigen
Ehrlich, P. H., Moustafa, Z. A., JUSTICE, J. C., Harfeldt, K. E., Kelley, R. L., & Östberg, L. (1992) · Human Antibodies · doi:10.3233/hab-1992-3101 · Cited by 26
Computational determination of the structure of rat fc bound to the neonatal fc receptor
Weng, Z., Gulukota, K., Vaughn, D. E., Björkman, P. J., & DeLisi, C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2020 · Cited by 20
Cited by
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Structure and function of immunoglobulins
Schroeder, H. W., & Cavacini, L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.046 · Cited by 1,905
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Enhanced antibody half-life improves in vivo activity
Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S., Leung, I. W. L., Sproule, T. J., Lazar, G. A., Roopenian, D. C., & Desjarlais, J. R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1601 · Cited by 653
Metadata
- Authors
- Hinton, P. R., Johlfs, M. G., Xiong, J. M., Hanestad, K., Ong, K. C., Bullock, C., Keller, S., Tang, M. T., Tso, J. Y., Vásquez, M., & Tsurushita, N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 8
- Pages
- 6213-6216
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2130611069
- Cited by
- 273
- References
- 36
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.